Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 033921/0787 | |
| Pages: | 5 |
| | Recorded: | 10/09/2014 | | |
| Attorney Dkt #: | 2144.0690002/RWE/SLE |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/31/2017
|
Application #:
|
14369539
|
Filing Dt:
|
06/27/2014
|
|
Publication #:
|
|
Pub Dt:
|
04/23/2015
| | | | |
|
Title:
|
Humanized Anti-Epiregulin Antibody, and Cancer Therapeutic Agent Comprising Said Antibody as Active Ingredient
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/31/2017
|
Application #:
|
14369539
|
Filing Dt:
|
06/27/2014
|
|
Publication #:
|
|
Pub Dt:
|
04/23/2015
| | |
PCT #:
|
JP2012084042
|
|
Title:
|
Humanized Anti-Epiregulin Antibody, and Cancer Therapeutic Agent Comprising Said Antibody as Active Ingredient
|
|
|
Assignee
|
|
|
|
|
| 5-1, UKIMA 5-CHOME, KITA-KU |
| TOKYO, JAPAN 115-8543 |
|
|
Correspondence name and address
|
| |
STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C
|
| |
1100 NEW YORK AVENUE, NW
|
| |
WASHINGTON, DC 20005
|
Search Results as of:
04/28/2024 11:04 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
